GE HealthCare Technologies Inc (NASDAQ: GEHC) has a higher price-to-earnings ratio of 14.96x compared to its average ratio. GEHC has 36-month beta value of 1.29. Analysts have mixed views on the stock, with 12 analysts rating it as a “buy,” 4 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for GEHC is 456.47M, and currently, short sellers hold a 1.49% ratio of that float. The average trading volume of GEHC on June 04, 2025 was 4.98M shares.
GEHC) stock’s latest price update
GE HealthCare Technologies Inc (NASDAQ: GEHC)’s stock price has soared by 1.44 in relation to previous closing price of 70.15. Nevertheless, the company has seen a gain of 0.21% in its stock price over the last five trading days. prnewswire.com reported 2025-06-02 that BOCA RATON, Fla., June 2, 2025 /PRNewswire/ — PharmaLogic Holdings Corp.
GEHC’s Market Performance
GE HealthCare Technologies Inc (GEHC) has experienced a 0.21% rise in stock performance for the past week, with a 0.89% rise in the past month, and a -15.60% drop in the past quarter. The volatility ratio for the week is 1.24%, and the volatility levels for the past 30 days are at 2.12% for GEHC. The simple moving average for the last 20 days is 0.10% for GEHC’s stock, with a simple moving average of -13.20% for the last 200 days.
Analysts’ Opinion of GEHC
Many brokerage firms have already submitted their reports for GEHC stocks, with UBS repeating the rating for GEHC by listing it as a “Neutral.” The predicted price for GEHC in the upcoming period, according to UBS is $73 based on the research report published on May 05, 2025 of the current year 2025.
Goldman, on the other hand, stated in their research note that they expect to see GEHC reach a price target of $100, previously predicting the price at $85. The rating they have provided for GEHC stocks is “Buy” according to the report published on March 11th, 2025.
Jefferies gave a rating of “Buy” to GEHC, setting the target price at $103 in the report published on January 08th of the current year.
GEHC Trading at 1.70% from the 50-Day Moving Average
After a stumble in the market that brought GEHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.94% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GEHC starting from Newcomb George A., who sale 2,000 shares at the price of $92.54 back on Feb 18 ’25. After this action, Newcomb George A. now owns 7,462 shares of GE HealthCare Technologies Inc, valued at $185,080 using the latest closing price.
Rott Roland, the CEO, Imaging of GE HealthCare Technologies Inc, sale 3,577 shares at $86.48 during a trade that took place back on Nov 06 ’24, which means that Rott Roland is holding 24,298 shares at $309,339 based on the most recent closing price.
Stock Fundamentals for GEHC
Current profitability levels for the company are sitting at:
- 0.14 for the present operating margin
- 0.42 for the gross margin
The net margin for GE HealthCare Technologies Inc stands at 0.11. The total capital return value is set at 0.12. Equity return is now at value 26.32, with 6.64 for asset returns.
Based on GE HealthCare Technologies Inc (GEHC), the company’s capital structure generated 0.5 points at debt to capital in total, while cash flow to debt ratio is standing at 0.17. The debt to equity ratio resting at 1.0. The interest coverage ratio of the stock is 5.73.
Currently, EBITDA for the company is 3.68 billion with net debt to EBITDA at 1.92. When we switch over and look at the enterprise to sales, we see a ratio of 1.99. The receivables turnover for the company is 4.55for trailing twelve months and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.94.
Conclusion
To put it simply, GE HealthCare Technologies Inc (GEHC) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
